PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+26.96%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.73B
AUM Growth
+$1.73B
(-47%)
Cap. Flow
-$1.86B
Cap. Flow
% of AUM
-107.4%
Top 10 Holdings %
Top 10 Hldgs %
41.62%
Holding
92
New
18
Increased
6
Reduced
30
Closed
31
Top Buys
| 1 |
Biogen
BIIB
|
$67.8M |
| 2 |
Elevance Health
ELV
|
$60M |
| 3 |
Centene
CNC
|
$51.5M |
| 4 |
Pfizer
PFE
|
$36.2M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
$31.7M |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$135M |
| 2 |
Penumbra
PEN
|
$100M |
| 3 |
NXP Semiconductors
NXPI
|
$82.4M |
| 4 |
Zimmer Biomet
ZBH
|
$81.6M |
| 5 |
Microchip Technology
MCHP
|
$78.4M |
Sector Composition
| 1 | Healthcare | 84.24% |
| 2 | Technology | 3.36% |
| 3 | Consumer Discretionary | 0.65% |
| 4 | Financials | 0.12% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Abbott
ABT
$230B
| $28M | 1.34% |
+322,713
| New | +$28M |
|
27
UnitedHealth
UNH
$279B
| $27.8M | 1.33% |
+94,699
| New | +$27.8M |
|
28
Envista
NVST
$3.37B
| $24.5M | 1.17% |
+825,732
| New | +$24.5M |
|
29
Edwards Lifesciences
EW
$47.7B
| $24.1M | 1.15% |
103,279
-148,475
| -59% | -$34.6M |
|
30
Molina Healthcare
MOH
$9.6B
| $24M | 1.14% |
176,964
-314,833
| -64% | -$42.7M |
|
31
Exact Sciences
EXAS
$9.33B
| $19.4M | 0.92% |
+209,839
| New | +$19.4M |
|
|
CTLT
32
DELISTED
CATALENT, INC.
CTLT
| $17.8M | 0.85% |
316,962
-789,811
| -71% | -$44.5M |
|
|
AXNX
33
DELISTED
Axonics, Inc. Common Stock
AXNX
| $15.2M | 0.73% |
550,026
+298,565
| +119% | +$8.27M |
|
34
AbbVie
ABBV
$374B
| $14.7M | 0.7% |
+166,239
| New | +$14.7M |
|
|
CSII
35
DELISTED
Cardiovascular Systems, Inc.
CSII
| $13.3M | 0.64% |
274,689
-190,356
| -41% | -$9.25M |
|
36
Vertex Pharmaceuticals
VRTX
$102B
| $12.5M | 0.59% |
+56,922
| New | +$12.5M |
|
|
AMRN
37
Amarin Corp
AMRN
$311M
| $11.4M | 0.54% |
+533,421
| New | +$11.4M |
|
38
Standard BioTools
LAB
$493M
| $11.3M | 0.54% |
3,234,984
+125,805
| +4% | +$438K |
|
39
Microsoft
MSFT
$3.76T
| $11.3M | 0.54% |
71,367
-179,236
| -72% | -$28.3M |
|
40
Halozyme
HALO
$8.75B
| $10.5M | 0.5% |
+593,480
| New | +$10.5M |
|
41
Salesforce
CRM
$245B
| $10.3M | 0.49% |
63,398
-287,024
| -82% | -$46.7M |
|
42
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $9.63M | 0.46% |
535,086
-154,739
| -22% | -$2.79M |
|
43
Alibaba
BABA
$325B
| $9.42M | 0.45% |
44,411
-36,793
| -45% | -$7.8M |
|
44
NVIDIA
NVDA
$4.15T
| $9.39M | 0.45% |
+39,889
| New | +$9.39M |
|
|
45
Microchip Technology
MCHP
$34.2B
| $8.55M | 0.41% |
81,671
-748,823
| -90% | -$78.4M |
|
|
46
NXP Semiconductors
NXPI
$57.5B
| $7.92M | 0.38% |
62,249
-647,681
| -91% | -$82.4M |
|
|
XYZ
47
Block, Inc.
XYZ
$46.2B
| $5.03M | 0.24% |
+80,427
| New | +$5.03M |
|
48
Intuit
INTU
$187B
| $4.39M | 0.21% |
16,747
-163,355
| -91% | -$42.8M |
|
|
ACOR
49
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $3.86M | 0.18% |
1,893,400
-292,857
| -13% | -$598K |
|
50
PayPal
PYPL
$66.5B
| $2.06M | 0.1% |
19,076
+3,840
| +25% | +$415K |
|